The Global pandemic Covid-19 since 2019 has changed the world as we know it. At Re&Source HUB we understand the importance of Health Care will be the main topic for the next half a century to come. In the next decade the world will see major shifts in the design and supply chain of Health Care, propelled by digital health, increasing financial constraints all accelerated by Covid-19. The health care industry evolves constantly, and advancements in technology is also affecting the OEM sector as it is one of the key drivers for innovation and speed efficiency. The OEM sector assists existing brands companies with manufacturing and supplying medical devices and equipment with products delivered in high quality and optimized costs to meet the industry’s stringent quality standards.
At Re&Source HUB it’s our mission to become one of the most important KEY drivers in the world market to promote improved quality Health Care for the Human race. We would like to transform along with the AI digital health revolution in the Health Care industry, as it has changed banking and retailing platforms already.
As people become more knowledgeable and active in their health care, the health industry should become more person oriented, personalized and transparent.
Sustainable cost structures, need to be attended in the world and especially in the sourcing and manufacturing sectors.
Health Care OEM (Original Equipment Manufacturer) market size is predicted to grow in size by year 2030 to USD214.90 million. It will be the key market drivers with increasing importance of quality healthcare products and demands for innovations in technology for health care IT.
Re&Source HUB is a strong sourcing partner for OEM products manufactured in Asia for patient monitoring and caring for patients in Hospitals and Senior homes across the globe including North America, Europe and Asia-Pacific. Our products sourced are also used in laboratory equipment and other medical applications encompassing diagnostic equipment, imaging systems, produced by our assured manufacturers which are high quality, high reliability, and customizable which caters to our customer’s specific needs.
We are working closely with our assured manufacturers to ensure we are meeting the growth in the industry for instances; Technological Advancements in AI improving accuracy in safety and processes; Increase in demand for high quality Health care products and services post pandemic; Cost optimization and efficiency in operations that will be more reliable and accurate while streamlining workflows.
For the trends of the Future; like Personalized medicine that is tailored to an individual’s specific genetic characteristics and needs; Remote patient monitoring post pandemic to develop more advanced monitoring wearable devices, AI assisted; Data analytics and Artificial Intelligence driven to improve clinical decision-making while enhancing patient outcomes.
At Re&Source HUB it is our mission to align with the ever evolving rapid and dynamic OEM healthcare market. We are your partner to drive efficiency through technology advancements, cost optimization with collaboration with our customers as leading healthcare providers. We will remain at the forefront of this industry and help source the needs of the global healthcare patients and improving the lives of our future generations.
Market Incubation via Delegate Models
Sales, Services, and Distribution Partnership
Digital and Omnichannel Services
Managing Laboratories, Repair
Market Incubation via Delegate Models
Sales, Services, and Distribution Partnership
Digital and Omnichannel Services
Managing Laboratories, Repair, or Service Centers
We understand that every business requires a tailored approach for its China strategy. We jointly develop and implement a China strategy with each of our brand partners. There is no one-size-fits-all; thus, our case studies reflect the variety of cooperation possibilities.
To increase the market participation of a German family SME that produces cardioplegic and organ preservation solutions in the field of cardiac and transplant surgery, the Group became a shareholder of the newly established local Joint Venture company in China and provides a one-stop-shop administration, supervision and corporate governance solution, which includes management representation, and ensures smooth and compliant day-to-day operations.
To ensure a smooth running of clients’ business in Asia and allow their focus to be solely on operations, China provides Corporate Services to the Asia Headquarter of a German manufacturer of ophthalmological instruments in Hong Kong.
China is the sole sales and after-sales partner of a Slovenian producer of medical consumables for the Chinese pharma industry. We have developed key accounts with the regular annual delivery of several dozens of million medical tampons to Chinese TCM manufacturers.
In the field of pharma and daily care packaging, as well as pharma machinery, our machinery and industrial business unit represent several brands in the Chinese market. Learn more about what we have done.
Learn about recent trends in the Chinese healthcare market and what we have done in our insight section.
In the field of pharma and daily care packaging, as well as pharma machinery, our machinery and industrial business unit represent several brands in the Chinese market. Learn more about what we have done.